Cargando…
Iron as the Key Modulator of Hepcidin Expression in Erythroid Antibody-Mediated Hypoplasia
Erythroid hypoplasia (EH) is a rare complication associated with recombinant human erythropoietin (rHuEPO) therapies, due to development of anti-rHuEPO antibodies; however, the underlying mechanisms remain poorly clarified. Our aim was to manage a rat model of antibody-mediated EH induced by rHuEPO...
Autores principales: | Fernandes, J. C., Garrido, P., Ribeiro, S., Rocha-Pereira, P., Bronze-da-Rocha, E., Belo, L., Costa, E., Reis, F., Santos-Silva, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281449/ https://www.ncbi.nlm.nih.gov/pubmed/25580431 http://dx.doi.org/10.1155/2014/421304 |
Ejemplares similares
-
Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model
por: Garrido, Patrícia, et al.
Publicado: (2015) -
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
por: Coffey, Richard, et al.
Publicado: (2018) -
Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients
por: Belo, Luís, et al.
Publicado: (2019) -
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia
por: Garrido, Patrícia, et al.
Publicado: (2015) -
Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia
por: Mirciov, Cornel S. G., et al.
Publicado: (2017)